23rd Edition Strategic Project & Portfolio Management for Pharma 2023 | GFMI | 24 January 2023 | Renaissance Barcelona Hotel, C/ de Pau Claris, 122, 08009 Barcelona, Spain

Past year has brought into focus the need to prioritize better and deliver results under increased budget constraints, but also to seize new opportunities, new business models, and accelerate R&D development.
This conference will provide a unique opportunity for professionals in the field of strategic portfolio management, to discuss how efficiently to select and value portfolios from early to late-stage projects, how to make critical decisions on processes, balancing risks, and opportunities, while adapting resources and budget. We will explore data analytics, AI, and machine learning's impact on drug development, product choice strategy and understand competitive advantages by better forecast and align strategic corporate objectives. The conference will enable you to advance your PPM tools and methods to stay competitive and make robust decisions. You will have the opportunity to discuss all these topics and more in an open and engaging environment, with plenty of networking and brainstorming during interactive sessions.

Key Sessions:
• Articulate Your Priorities Better In An Uncertain Environment
• Balance Financial And Scientific Value To Ensure Project Portfolio Alignment With Strategy And Delivering Results Under Increased Volatility
• Explore The Impact Of Data Analytics, IA And Machine Learning Applied To R&D Portfolio Management
• Maximise Portfolio Value Under Limited Budget
• Explore How To Manage Capacities And Prioritise Between Projects
• Manage Innovation And Risk In The Early Pipeline

2023 Speakers

Tom Halliwell
Senior Vice President & Head of Operations, Ariceum Therapeutics, United Kingdom

Gilles Brackman
Vice President of R&D, Flen Health, Belgium

Mary Ann A. Lumiqued
Vice President of Program Management, Tubulis GmbH, Germany

Simone Frandsen
Director R&D Portfolio and Strategy, LEO Pharma, Denmark

Tom Benedetto
Executive Director, R&D Capabilities, Bristol Myers Squibb, United States

Nathalie Mondoly
Director, Pharmaceutical Development Transformation and Enterprise Excellence Pharmaceutical Development – R&D, Ipsen, France

Besaint Mehta Sahni
Director, Head of Program & Portfolio Management, Medical Products, Advanced Energy, United States

Martine Mazzetti
Head of Project Leadership, VectivBio, Switzerland

Audrey Robinson-Ballard
Associate Director, Pharmaceutical Project Management, Eli Lilly and Company, United States

David Yee
Head, Portfolio Systems, Novartis, United States

Thorsten Knoechel
Head, R&D Governance Operations, Merck, Germany

Benedicte Calvet
Global Head of Medical Operations, Pierre Fabre, France

Norbert Leinfellner
Head of PMO, Element Science, United States

Caroline Miklaszewski
Project Director - Rare Diseases, Pierre Fabre, France

Manfred Schwaiger
Head of Business Enabling- pRED Oncology, F. Hoffmann-La Roche, Switzerland

Marcel Hoogenraad
Project Manager R&D, Grunenthal Group, Germany

Hana Janouskova
Research Project Manager, F. Hoffmann-La Roche, Switzerland

Beat R. Schybli
Portfolio Management and PMO Lead, Takeda, Switzerland

Tobias Koshubs
Research Project Manager, Bayer, Germany

Heidi Peachey
Portfolio Manager, Cancer Research UK, United Kingdom

Bruno Cocheteux
CEO, JBT HubUp

2023 Sponsors and Partners

SPONSORS:
• Captario
• Cylad Consulting
• JBT

MEDIA PARTNERS:
• Association for Project Management
• PIPMG
• Innoget
• Swiss Biotech Association